RAPPOSELLI, SIMONA
 Distribuzione geografica
Continente #
EU - Europa 2.109
NA - Nord America 107
AS - Asia 84
SA - Sud America 9
AF - Africa 3
Totale 2.312
Nazione #
IT - Italia 2.074
US - Stati Uniti d'America 103
SG - Singapore 45
CN - Cina 27
SE - Svezia 9
BR - Brasile 8
FR - Francia 6
FI - Finlandia 4
CA - Canada 3
HK - Hong Kong 3
PL - Polonia 3
RU - Federazione Russa 3
VN - Vietnam 3
DE - Germania 2
GB - Regno Unito 2
ZA - Sudafrica 2
AL - Albania 1
AT - Austria 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BY - Bielorussia 1
ES - Italia 1
IQ - Iraq 1
JP - Giappone 1
KZ - Kazakistan 1
MA - Marocco 1
MT - Malta 1
MX - Messico 1
NO - Norvegia 1
PK - Pakistan 1
VE - Venezuela 1
Totale 2.312
Città #
Cagliari 1.932
Uta 126
Singapore 27
Ashburn 20
Boardman 11
Los Angeles 9
The Dalles 8
Nyköping 7
Beijing 6
Pisa 6
Santa Clara 6
New York 5
Shanghai 5
Dallas 4
Helsinki 3
Hong Kong 3
Livorno 3
Redondo Beach 3
Warsaw 3
Bologna 2
Denver 2
Johannesburg 2
Quarrata 2
Saratov 2
Stockholm 2
Almaty 1
Anápolis 1
Asolo 1
Baku 1
Basra 1
Brooklyn 1
Buffalo 1
Bắc Giang 1
Carney 1
Casablanca 1
Chicago 1
Florence 1
Gujranwala 1
Hanoi 1
Harrisburg 1
Heishan 1
Ho Chi Minh City 1
Jackson 1
Jacksonville 1
Juazeiro do Norte 1
Lappeenranta 1
Lauterbourg 1
Longyan 1
Manchester 1
Montreal 1
Mosta 1
Nirgua 1
Nova Serrana 1
Nuremberg 1
Orem 1
Oslo 1
Paris 1
Portsmouth 1
Querétaro 1
Rio de Janeiro 1
Rolândia 1
San Francisco 1
Santa Maria da Vitória 1
São Gabriel 1
Taboão da Serra 1
Tianjin 1
Tirana 1
Tokyo 1
Toronto 1
Turin 1
Vancouver 1
Wuhan 1
Wuxi 1
Totale 2.247
Nome #
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 697
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 567
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 376
Novel thyroid hormone receptor beta agonist TG68 safely induces hepatic fat loss reduction in a NASH mouse model 375
Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis 303
Totale 2.318
Categoria #
all - tutte 3.433
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.433


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023280 0 0 0 11 26 24 49 17 38 43 57 15
2023/2024602 35 17 18 26 62 86 109 74 31 30 48 66
2024/20251.304 389 411 109 135 50 42 111 8 9 15 10 15
2025/2026132 22 11 24 25 45 5 0 0 0 0 0 0
Totale 2.318